March 2025 has seen “Stand up for Science” events take place in cities in both the U.S. and France. Reliable, reputable research is essential for fostering advances in human health. The Endocrine Society is extremely active in advocating for science funding and health policy, with particular emphasis on the endocrine space. The Society also has...
A major reorganization of the U.S. Department of Health and Human Services (HHS) — including massive cuts to the federal workforce — threatens scientific progress that drives our economy and improves the public’s health. Slashing federal funding and staff will hobble the very agencies that fuel medical discoveries and approve new treatments. In addition, the...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * CABOMETYX® Receives FDA Approval to Treat Neuroendocrine Tumors On March 26, Exelixis, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with...
Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, has been elected Fellow of the American Association for the Advancement of Science (AAAS) — one of the world’s largest and most prestigious scientific societies and publisher of the Science journals. The lifetime honor recognizes...
Three decades of landmark research into type 2 diabetes prevention abruptly ended this month due to government funding cuts. The Endocrine Society calls on the administration to restore the Diabetes Prevention Program (DPP) and DPP Outcomes Study funded through the National Institutes of Health. The Society is concerned about how the loss of this ongoing...
On March 18, Queen’s University in Kington, Ontario, Canada, announced that Lisa Tannock, MD, was appointed dean, Queen’s Health Sciences, and director of the School Medicine, effective July 1. Tannock will join Queen’s University from the University of Kentucky, where she is associate provost for faculty advancement and a professor in the Division of Endocrinology,...
On March 13, the Board of Trustees of the University of Pennsylvania voted unanimously to appoint Endocrine Society Past-President J. Larry Jameson, MD, PhD, who has served as interim president since December 2023, president of the University for a term that will run through June 30, 2027. In announcing the appointment, Chair of the Board...
Endocrine Society members elected Nanette Santoro, MD (left) of the University of Colorado School of Medicine in Aurora, Colo., as its 2026-2027 President. She will serve as President-Elect for a year beginning in July 2025 before becoming President in June 2026. Santoro has served as E. Stewart Taylor Chair of Obstetrics & Gynecology at the...
March 2025 has seen “Stand up for Science” events take place in cities in both the U.S. and France. Reliable, reputable research is essential for fostering advances in human health. The Endocrine Society is extremely active in advocating for science funding and health policy, with particular emphasis on the endocrine space. The Society also has...
Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, has been elected Fellow of the American Association for the Advancement of Science (AAAS) — one of the world’s largest and most prestigious scientific societies and publisher of the Science journals. The lifetime honor recognizes...
On March 13, the Board of Trustees of the University of Pennsylvania voted unanimously to appoint Endocrine Society Past-President J. Larry Jameson, MD, PhD, who has served as interim president since December 2023, president of the University for a term that will run through June 30, 2027. In announcing the appointment, Chair of the Board...